ok that worked well...what I meant to say was...
the wording on page 15 'major pharma partners' appears to be quite specific;
Roche - collaboration - no mention of future cashflows
Medimmune - deal - 'can receive...'
Pfizer - license - 'can receive...'
Janssen - collaboration - no mention of future cashflows
Genentech - 'licensing deal' - 'can receive...'
I suspect the author has looked at each document and determined which are still live, albeit in hibernation. Perhaps reading too much into it...
ok that worked well...what I meant to say was... the wording on...
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |